NIH Launches Trial of Rigel Drug for Severe COVID-19 NIH Launches Trial of Rigel Drug for Severe COVID-19

The NIH on Thursday launched a clinical trial of fostamatinib, currently used to treat a blood platelet-destroying autoimmune disorder, in patients hospitalized with severe COVID-19.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news